Clinical trial · Interventional
Three Times Weekly Symptom Screening for Children With Cancer
A Feasibility Study of Three Times Weekly Symptom Screening for Children With Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will evaluate the feasibility of three times weekly symptom reporting by children using the SPARK platform for 8 weeks. SPARK is a web-based application that promotes symptom screening for children receiving cancer therapies and enables access to clinical practice guidelines for symptom management. Newly diagnosed and relapsed patients with cancer will be enrolled. Children and/or their guardian will be prompted to complete symptom screening three times weekly via SPARK with corresponding feedback sent to their healthcare providers with each completed assessment. Symptom reports will contain links to clinical practice guidelines for symptom management. Active intervention will last for 8 weeks starting from the date of enrollment.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Relapsed Cancer | Malignant Neoplasm | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| SPARK | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Three times weekly symptom screening
- description
- Three times weekly symptom reporting by guardians and children using the SPARK platform for 8 weeks
- interventionNames
- Other: SPARK
Primary outcomes (1)
- measure
- Feasibility of three times weekly symptom reporting by children using the SPARK platform for 8 weeks.
- timeFrame
- 8 weeks
- description
- The primary endpoint is feasibility, defined as at least 75% achieving compliance with at least 60% of symptom evaluations among guardian and self-report populations.
Secondary outcomes (7)
- measure
- Symptom burden as measured by the total SSPedi score Total SSPedi symptom scores
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 2 Years
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * cancer diagnosis * 2-18 years of age at enrollment * Child has received or a plan for any chemotherapy, radiotherapy or surgery * Understands English, French or Spanish Exclusion Criteria: * Cognitive disability * Visual impairment (cannot see SPARK even with corrective lens)
References
Publications (0)
Data not yet available